189 related articles for article (PubMed ID: 30642929)
1. Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients.
Li SC; Ye Q; Xu H; Zhang L; Wang Y
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642929
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients.
Ogami C; Tsuji Y; To H; Yamamoto Y
J Infect Chemother; 2019 Dec; 25(12):979-986. PubMed ID: 31208925
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants.
Shi ZR; Chen XK; Tian LY; Wang YK; Zhang GY; Dong L; Jirasomprasert T; Jacqz-Aigrain E; Zhao W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378703
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study.
Wang X; Wang Y; Yao F; Chen S; Hou Y; Zheng Z; Luo J; Qiu B; Li Z; Wang Y; Wu Z; Lan J; Chen C
Drug Des Devel Ther; 2021; 15():2129-2141. PubMed ID: 34040351
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens.
Hirt D; Oualha M; Pasquiers B; Blanot S; Rubinstazjn R; Glorion C; Messaoudi SE; Drummond D; Lopez V; Toubiana J; Béranger A; Boujaafar S; Zheng Y; Capito C; Winter S; Léger PL; Berthaud R; Gana I; Foissac F; Tréluyer JM; Bouazza N; Benaboud S
Eur J Clin Pharmacol; 2021 Nov; 77(11):1687-1695. PubMed ID: 34160669
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.
Maksoud E; Koehl B; Facchin A; Ha P; Zhao W; Kaguelidou F; Benkerrou M; Mariani P; Faye A; Lorrot M; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378711
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
Thorsted A; Kristoffersson AN; Maarbjerg SF; Schrøder H; Wang M; Brock B; Nielsen EI; Friberg LE
J Antimicrob Chemother; 2019 Oct; 74(10):2984-2993. PubMed ID: 31273375
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
Cojutti P; Pai MP; Pea F
Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
Nichols K; Chung EK; Knoderer CA; Buenger LE; Healy DP; Dees J; Crumby AS; Kays MB
Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection.
Zhi LJ; Wang L; Chen XK; Zhai XY; Wen L; Dong L; Jacqz-Aigrain E; Shi ZR; Zhao W
Drug Des Devel Ther; 2018; 12():855-862. PubMed ID: 29713143
[TBL] [Abstract][Full Text] [Related]
12. Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity.
Luque S; Hope W; Sorli L; Muñoz-Bermudez R; Campillo N; Barceló-Vidal J; Álvarez-Lerma F; Horcajada JP; Masclans-Enviz JR; Neely M; Grau S
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820765
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetic Analysis and Dose Regimen Optimization in Japanese Infants with an Extremely Low Birth Weight.
Sasano H; Aoki K; Arakawa R; Hanada K
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318009
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics and Dosing Regimen Optimization of Linezolid in Cerebrospinal Fluid and Plasma of Post-operative Neurosurgical Patients.
Li S; Wang Y; Dong H; Zhu Y; Cao P; Meng L; Wang Y
J Pharm Sci; 2023 Mar; 112(3):884-892. PubMed ID: 36566928
[TBL] [Abstract][Full Text] [Related]
15. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.
Hennig S; Norris R; Kirkpatrick CM
Br J Clin Pharmacol; 2008 Apr; 65(4):502-10. PubMed ID: 17995972
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia.
Xie F; Mantzarlis K; Malliotakis P; Koulouras V; Degroote S; Koulenti D; Blot S; Boussery K; Van Bocxlaer J; Colin P;
J Antimicrob Chemother; 2019 Mar; 74(3):667-674. PubMed ID: 30535122
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children.
Li S; Shu C; Wu S; Xu H; Wang Y
Front Pharmacol; 2020; 11():614164. PubMed ID: 33536921
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
Garcia-Prats AJ; Schaaf HS; Draper HR; Garcia-Cremades M; Winckler J; Wiesner L; Hesseling AC; Savic RM
PLoS Med; 2019 Apr; 16(4):e1002789. PubMed ID: 31039153
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction.
Zhang SH; Zhu ZY; Chen Z; Li Y; Zou Y; Yan M; Xu Y; Wang F; Liu MZ; Zhang M; Zhang BK
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253210
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
